Risk factor
Low price volatility
Profitability factor
Favourable analyst view
About
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company provides discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and analytical chemistry; and discovery biology services in the areas of...
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITD.
Target Price
The average target price of SYNGENE.NS is 748 and suggests 83% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i
Buy
Sell